Measure ID
ABX-06-OB
Description

Percentage of unscheduled cesarean deliveries in which azithromycin was administered within 60 minutes before incision.

Measure Type
Process
Available for Provider Feedback
Yes
Threshold
80
Rationale

Cesarean delivery is a significant risk factor for postpartum uterine infection, associated with a 5-to-10-fold increase in infectious morbidity compared to vaginal delivery1. The use of azithromycin in women undergoing non-elective cesarean deliveries has been shown to reduce the risk of postoperative infections1. Moreover, azithromycin use significantly decreases the rates of endometritis, wound infections, and serious maternal adverse events2.  Research by Sanusi et al. indicates that administering azithromycin up to 60 minutes before incision is effective in reducing the risk of postoperative infection, a practice also supported by the American College of Obstetricians and Gynecologists (ACOG) 1,3.  It is recommended that the antibiotic be infused before the incision to achieve peak antimicrobial concentrations in the tissue at the time of incision1. Skeith et al. used a TreeAge cost-effectiveness model to compare outcomes of a theoretical cohort of 700,000 women4. They found that for women who undergo cesarean delivery during labor or after membrane rupture adding azithromycin to cephalosporin is less costly and results in better maternal outcomes in the index and subsequent deliveries4.

Measure Time Period

60 min before Surgical Incision through Surgical Incision

Inclusions

Enumerations 1 and 7 using OBAT  (Non-elective cesarean cases.)

Success Criteria

Non-elective cesarean patients who received azithromycin within the measure time period.

Other Measure Details

Both PO Vancomycin and IV routes will be accepted for this measure to pass.

 

Measure start time: 

60 minutes before Surgical Incision time (50235). If no Procedure start time is documented, Surgical AACD Procedure Start will be used. If no Surgical Incision available will use Uterine Incision. If uterine incision is not available will use delivery of neonate 50358, or 50189) 

  • For cases without a documented surgical incision time or procedure start time, the case will be flagged for review.
  • Measure will only look for the prophylactic variance note (as determined by the ABX Notes Phenotype) if an antibiotic is not documented within the measure time frame. 
  • Cases will be flagged for review if there is documentation that an antibiotic was not ordered or there is documentation that the antibiotic is ‘not indicated.’
  • Cases will be assigned one of the following results:
    • Passed - Antibiotic administered on time
    • Flagged- No Azithromycin Administered
    • Flagged- Antibiotic not ordered/indicated per surgeon
    • Flagged- Incision/procedure start time documented: No
    • Flagged- Azithromycin administered too late
    • Flagged- Azithromycin administered too early
    • Excluded- Chorioamnionitis diagnosis
    • Excluded- Scheduled antibiotics/documented infection
    • Exclusion- Excluded procedure (OBAT enumeration 0, 2, 3, 4, 5, 6)

Measure End Time- Earliest time from:

  • Surgical incision
  • Procedure start
  • Uterine Incision
  • Delivery of neonate
  • Delivery of neonate 2

*This measure will include only valid MPOG cases as defined by the Is Valid Case phenotype.

Risk Adjustment

Not Applicable.

Provider Attribution

All providers signed in during measure time period.

MPOG Concept Used

MPOG Concept ID

Concept Description

Medication

10048

Azithromycin - both PO and IV are accepted 

Measure Time

50002

Anesthesia Start

50009

Anesthesia End

Obstetric Concepts

50181 

Compliance - Prophylactic antibiotic variance note 

50182

Compliance - Prophylactic antibiotic variance detail

50189

Delivery of Neonate 2

50235

Surgical Incision

50358

Delivery of Neonate 

50622

Compliance - Antibiotic Started

 

 

MPOG Phenotypes Used
References

References:

  1. Sanusi A, YeYBoggess K,  Saade G, Longo S, Clark E, Esplin S, Cleary K, Wapner R, Owens M,  Blackwell S, Szychowski JM, Tita ATN, Subramaniam A,  Timing of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Post Delivery Infection. Obstet Gynecol.  2022 June 1;139(6):1043-1049.doi: 10.1097/AOG.0000000000004788. Epub 2022 May 2.
  2. Tita AT, Szychowski JM, Boggess K, Saade G, Longo S, Clark E, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Abramovici A, Ambalavanan N, Cutter G, Andrews W; C/SOAP Trial Consortium. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. N Engl J Med. 2016 Sep 29;375(13):1231-41. doi: 10.1056/NEJMoa1602044. PMID: 27682034; PMCID: PMC5131636.
  3. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstetrics & Gynecology 132(3):p e103-e119, September 2018. | DOI: 10.1097/AOG.0000000000002833 
  4. Skeith AE, Niu B, Valent AM, Tuuli MG, Caughey AB. Adding azithromycin to cephalosporin for cesarean delivery infection prophylaxis: A cost-effectiveness analysis.  Obstet Gynecol. 2017 Dec; 130(6):1279-1284.
Measure Authors

 Name

Institution

 Monica Servin

 University of Michigan

 Brandon Togioka

 Oregon Health and Science University

 Lawrence Tsen

 Harvard Medical School

 Nicole Barrios

 University of Michigan

 Rob Coleman

 University of Michigan